AbbVie vs AMD: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. AMD was founded in 1969 by Jerry Sanders, Edwin Turney and is led by Lisa Su.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
AMD
Jerry Sanders
Advanced Micro Devices (AMD) was founded in May 1969 by Jerry Sanders, a charismatic, flamboyant electrical engineer, along with seven of his colleagues from Fairchild Semiconductor (the well-known incubator of Silicon Valley that also birthed Intel).
Edwin Turney
Edwin Turney helped establish the operating foundation behind AMD's early logic-device business. While Sanders became the public face, Turney's contribution was making sure the company could earn trust through production reliability and execution.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
AMD
- Jerry Sanders1969–2002
CEO
Sanders, born in Chicago in 1936, worked at Douglas Aircraft and Motorola before joining Fairchild Semiconductor in 1961, where he rose to head worldwide sales and marketing.
Source - Hector Ruiz2002–2008
CEO
Ruiz grew up in Piedras Negras, Mexico, and as a teenager crossed the US border daily to attend high school in Eagle Pass, Texas, graduating valedictorian only three years after learning English.
Source - Dirk Meyer2008–2011
CEO
Meyer, a University of Illinois computer-engineering graduate with an MBA from Boston University, co-architected the Alpha 21064 and 21264 microprocessors at Digital Equipment Corporation before joining AMD in 1996, where he personally led development of the o…
Source - Rory Read2011–2014
CEO
Read spent 23 years at IBM in global leadership roles before becoming president and COO of Lenovo, and holds an information-sciences degree from Hartwick College.
Source - Lisa Su2014–present
CEO
Born in Taiwan and raised in the United States, Su earned bachelor's, master's and doctorate degrees in electrical engineering from MIT and worked at Texas Instruments, IBM and Freescale Semiconductor before joining AMD in 2012 as senior vice president of glob…
Source
Timeline: AbbVie and AMD side by side
1969AMD
Advanced Micro Devices Founded
Jerry Sanders and seven colleagues from Fairchild Semiconductor founded AMD on May 1, 1969, and broke ground that year on the 915 DeGuigne building in Sunnyvale, California, which remained the headquarters for more than 47 years.
1975AMD
Entry Into Microprocessors
AMD entered the microprocessor market in 1975, moving beyond the logic devices it started with. The decision put it into direct competition with Intel and made x86 compatibility the center of its business for the next four decades.
1999AMD
Athlon Breakthrough
Athlon launched in 1999 and matched or beat Intel on desktop performance. In March 2000 AMD announced the first 1 GHz x86 processor, days ahead of Intel, which changed how enthusiasts and PC makers judged the company.
2005AMD
Antitrust Lawsuit Against Intel
AMD sued Intel in 2005, alleging rebates and exclusionary practices that limited its access to PC makers.
2006AMD
ATI Technologies Acquired
AMD acquired ATI Technologies in 2006 for about $5.4B to add graphics and chipsets. The debt-funded deal strained the balance sheet just as Intel shipped Core 2, but ATI became the basis for Radeon graphics, console APUs, and later Instinct accelerators.
2009AMD
Fabless Pivot Through GlobalFoundries
AMD moved its manufacturing operations into GlobalFoundries in 2009 and stopped owning fabs. The change removed billions of annual capital spending and let AMD buy leading-edge capacity, but it also tied the product roadmap to outside foundries.
2011AMD
Bulldozer Architecture Failure
Bulldozer traded single-thread performance for core count at a time when most software depended on per-core speed. Reviews were poor, PC maker confidence fell, and server share collapsed, which is what forced the clean-sheet Zen project.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2014AMD
Lisa Su Becomes CEO
AMD's board appointed Lisa Su president and CEO on October 8, 2014, succeeding Rory Read. She narrowed the company around high-performance computing and put the engineering budget behind the Zen CPU core rather than spreading it across incremental projects.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2017AMD
Ryzen, EPYC, and Chiplets Rebuild AMD
Zen reached the market in 2017 as Ryzen for desktops and EPYC for servers. Chiplet packaging over Infinity Fabric let AMD build high core-count parts from smaller dies, improving usable yield and giving it a cost structure Intel's monolithic designs could not…
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2022AMD
Xilinx Acquisition
AMD completed the Xilinx acquisition in February 2022. The all-stock deal was announced in October 2020 at about $35B and was worth roughly $49B at close.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025AMD
ZT Systems Acquired and Its Factories Sold
AMD closed the ZT Systems purchase on March 31, 2025, paying $3.2B in cash plus 8.3 million shares for rack-scale AI systems design.
2025AMD
OpenAI Agrees to Deploy 6 Gigawatts of AMD GPUs
On October 6, 2025 AMD and OpenAI announced a multi-year agreement covering 6 gigawatts of AMD GPUs, starting with a 1 gigawatt Instinct MI450 deployment in the second half of 2026.
2025AMD
Record $34.6B Revenue
AMD reported FY2025 revenue of $34.6B, up 34%, with net income of $4.3B and a 50% gross margin.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026AMD
Meta Agrees to Deploy Up to 6 Gigawatts of AMD GPUs
On February 24, 2026 AMD and Meta announced a multi-year agreement for up to 6 gigawatts of Instinct GPUs.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
AMD
- ZT Systems2025$4.9B
- Silo AI2024$665M
- Xilinx2022$49B
- Pensando Systems2022$1.9B
- ATI Technologies2006$5.4B
Questions about AbbVie vs AMD
Who is the CEO of AbbVie Inc. and Advanced Micro Devices, Inc.?
AbbVie Inc. is led by Robert A. Michael and Advanced Micro Devices, Inc. is led by Lisa Su. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Advanced Micro Devices, Inc.?
Advanced Micro Devices, Inc. was founded in 1969 — 44 years before AbbVie Inc., which was founded in 2013. Advanced Micro Devices, Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Advanced Micro Devices, Inc.?
AbbVie Inc. employs approximately 57,000 people, while Advanced Micro Devices, Inc. employs approximately 31,000. AbbVie Inc. has the larger workforce at 57,000 employees, compared to Advanced Micro Devices, Inc.'s 31,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Advanced Micro Devices, Inc. headquartered?
Both AbbVie Inc. and Advanced Micro Devices, Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Advanced Micro Devices, Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Advanced Micro Devices, Inc. was founded by Jerry Sanders, Edwin Turney.
Which company has a longer operating history — AbbVie Inc. or Advanced Micro Devices, Inc.?
Advanced Micro Devices, Inc. has been operating for approximately 57 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs AMD overview